EXPERT CONSENSUS DOCUMENT ON MANAGEMENT OF CARDIOVASCULAR DISEASES DURING PREGNANCY

1. Whittemore R, Hobbins J, Engle M. Pregnancy and its outcome in women with and without surgical treatment of congenital heart disease. Am J Cardiol 1982;50:641–51.

2. Mc Faul P, Dornan J, Lamki H et al. Pregnancy complicated by maternal heart disease. A review of 519 women. Br J Obstet Gynaecol 1988;95:861–7.

3. Morgan Jones A, Howitt G. Eisenmenger syndrome in pregnancy. Br Med J 1965;1:1627.

4. Weiss BM, Hess OM. Pulmonary vascular disease and pregnancy: current controversies, management and perspectives. Eur Heart J 2000;21:104–5.

5. Siu SC, Sermer M, Harrison DA et al. Risk and predictors for pregnancy related complications in women with heart disease. Circulation 1997;96:2789–94.

6. Robson SC, Hunter S, Boys RJ et al. Serial study of factors influencing changes in cardiac output during human pregnancy. Am J Physiol 1989;256:H1060–5.

7. Robson SC, Dunlop W, Boys RJ et al. Cardiac output during labour. Br Med J 1987;295:1169–72.

8. Elkayam U, Gleicher N. Hemodynamics and cardiac function during normal pregnancy and the puerperium. In: Elkayam, Gleicher N, editors. Cardiac problems in pregnancy. New York: Wiley; 1998, p. 3–19.

9. Oakley C. Pulmonary hypertension in heart disease in pregnancy. London: BMJ Publishing Group, 1997, p. 97–111.

10. Oakley C. Acyanotic congenital heart disease. Heart disease in pregnancy. London: BMJ Publishing Group; 1997, p. 63–82.

11. Presbitero P, Somerville J, Stone S et al. Pregnancy in cyanotic congenital heart disease. Outcome of mother and fetus. Circulation 1994;89:2673–6.

12. Presbitero P, Prever SB, Brusca A. Interventional cardiology in pregnancy. Eur Heart J 1996;17:182–8.

13. Pomini F, Mercogliano D, Cavalletti C et al. Cardiopulmonary bypass in pregnancy. Ann Thorac Surg 2000;61:259–68.

14. Vajifdar BU, Gupta AK, Kerkar PG et al. Pre-natal echo-cardiographic diagnosis and neonatal balloon dilatation of severe valvar pulmonic stenosis. Indian J Pediatr 1999;66:799–803.

15. Burn J, Brennan P, Little J et al. Recurrence risks in offspring of adults with major heart defects. Results from first cohort of British collaborative study. Lancet 1998; 351:311–6.

16. Deal K. Woolley coarctation of the aorta and pregnancy. Ann Intern Med 1973;78:706–10.

17. Genoni M, Jenni R, Hoerstrup SP et al. Pregnancy after atrial repair for transposition of the great arteries. Heart 1999; 81:276–7.

18. Connnolly HM, Grogan M, Warnes CA. Pregnancy among women with congenitally corrected transposition of the great arteries. J Am Coll Cardiol 1999;84:820–4.

19. Canobbio M, Mair D, van der Velde M et al. Pregnancy outcomes after the Fontan repair. J Am Coll Cardiol 1996; 28:763–7.

20. Tan HL, Lie KI. Treatment of tachyarrhythmias during pregnancy and lactation. Eur Heart J 2001;22:458–64.

21. Bloomfield TH, Hawkins DF. The effect of drugs on the human fetus. In: Setchell, Ginsberg, editors. Scientific foundations of obstetrics and gynaecology. Oxford: Butterworth Heinemann; 1991, p. 320–36.

22. Magee LA, Downar E, Sevner M et al. Pregnancy outcome after gestational exposure to amiodarone in Canada. Am J Obstet Gynecol 1995;172:1307–11.

23. James C, Banner T, Caton D. Cardiac output in women undergoing caesarean section with epidural or general anesthesia. Am J Obstet Gynecol 1989;160:1178–82.

24. De Paepe A, Devereux R, Dietz H et al. Revised diagnostic criteria for the Marfan syndrome. Am J Med Genet 1996; 62:417–26.

25. Child AH. Marfan syndrome — current medical and genetic knowledge: how to treat and when. J Card Surg 1997;12(Suppl):131–6.

26. Child AH. Pregnancy management in Marfan syndrome and other connective tissue disorders. In: Oakley C, editor. Management of pregnancy in women with cardiac disease. London: BMA publications; 1997, p. 153–62.

27. Pyeritz R. Maternal and fetal complications of pregnancy in the Marfan syndrome. Am J Med 1981;71:784–90.

28. Rossiter J, Repke JT, Morales AJ et al. A prospective longitudinal evaluation of pregnancy in women with Marfan syndrome. Am J Obstet Gynecol 1995; 183:1599–606.

29. Lipscomb KJ, Smith JC, Clarke B et al. Outcome of pregnancy in women with Marfan syndrome. Br J Obstet Gynaecol 1997;104: 201–6.

30. Erbel R, Alfonso F, Boileau C et al. Task force report: diagnosis and management of aortic dissection. Eur Heart J 2001;22:1642–81.

31. Gott VL, Pyeritz RE, Magovern GJ Jr. et al. Surgical treatment of aneurysms of the ascending aorta in the Marfan syndrome: results of composite-graft repair in 50 patients. N Engl J Med 1986;314: 1070–4.

32. Yacoub MH, Gehle P, Chandrasekaran V et al. Late results of a valvepreserving operation in patients with aneurysms of the ascending aorta and root. J Thorac Cardiovasc Surg 1998;115(5):1080–90.

33. Pinosky ML, Hopkins RA, Pinckert TL et al. Anaesthesia for simultaneous cesarean section and acute aortic dissection repair in a patient with Marfan syndrome. J Cardiothorac Vasc Anesth 1994;8:451–4.

34. Pyeritz R, Fishman EK, Bernhardt BA et al. Dural ectasia is a common feature of Marfan syndrome. Am J Hum Genet 1988;43(5): 726–32.

35. Steinmann B, Royce PM, Superti-Furga A. The Ehlers–Danlos syndrome. In: Royce PM, Steinmann B, editors. Connective tissue and its heritable disorders. New York: Wiley; 1993, p. 351–457.

36. Pope FM, Narcisi P, Nicholls AC et al. COL3A1 mutations cause variable clinical phenotypes including acrogeria and vascular rupture. Br J Dermatol 1996;135:163–81.

37. Coady M, Davies R, Roberts M et al. Familial patterns of thoracic aortic aneurysms. Arch Surg 1999;134:361–7.

38. Furthmayr H, Francke U. Ascending aortic aneurysm with or without features of Marfan syndrome and other fibrillinopathies: new insights. Semin Thorac Cardiovasc Surg 1997; 9:191–205.

39. Iserin L, Jondeau G, Sidi D et al. Manifestations cardiovasculaires et indications therapeutiques. Arch Mal Coeur Vaiss 1997;90(Suppl): 1701–5.

40. Chia YT, Yeoh SC, Lim MC et al. Pregnancy outcome and mitral valve prolapse. Asia Oceania J Obstet Gynaecol 1994; 20:383–8.

41. Hagay ZJ, Weissman A, Geva D et al. Labor and delivery complicated by acute mitral regurgitation due to ruptured chordae tendineae. Am J Perinatol 1995;12:111–2.

42. Sheikh F, Rangwala S, DeSimone C et al. Management of the parturient with severe aortic incompetence. J Cardiothorac Vasc Anesth 1995;9:575–7.

43. Khandelwal M, Rasanen J, Ludormirski A et al. Evaluation of fetal and uterine hemodynamics during maternal cardiopulmonary bypass. Obstet Gynecol 996;88:667–71.

44. Hameed A, Karaalp IS, Tummala PP et al. The effect of valvular heart disease on maternal and fetal outcome during pregnancy. J Am Coll Cardiol 2001;37:893–9. 45. Bryg RJ, Gordon PR, Kudesia VS et al. Effect of pregnancy on pressure gradient in mitral stenosis. Am J Cardiol 1989; 63:384–6.

45. Avila WS, Grinberg M, Decourt LV et al. Clinical course of women with mitral valve stenosis during pregnancy and puerperium. Arq Bras Cardiol 1992;58:359–64.

46. Al Kasab SM, Sabag T, Al Zaibag M et al. Beta-adrenergic receptor blockade in the management of pregnant women with mitral stenosis. Am J Obstet Gynecol 1990;163:37–40.

47. Butters L, Kennedy S, Rubin PC. Atenolol in essential hypertension during pregnancy. Br Med J 1990;301:587–9.

48. Clark SL, Phelan JP, Greenspoon J et al. Labor and delivery in the presence of mitral stenosis: central hemodynamic observations. Am J Obstet Gynecol 1985;152:984–8.

49. Jakobi P, Adler Z, Zimmer EZ et al. Effect of uterine contractions on left atrial pressure in a pregnant woman with mitral stenosis. Br Med J 1989;298:27.

50. Ducey JP, Ellsworth SM. The hemodynamic effects of severe mitral stenosis and pulmonary hypertension during labor and delivery. Intensive Care Med 1989;15:192–5.

51. Zitnik RS, Brandenburg RO, Sheldon R et al. Pregnancy and openheart surgery. Circulation 1969;39(Suppl 1):257–62.

52. Bernal JM, Miralles PJ. Cardiac surgery with cardiopulmonary bypass during pregnancy. Obstet Gynecol Surv 1986;41:1–6.

53. Sullivan HJ. Valvular heart surgery during pregnancy. Surg Clin North Am 1995;75:59–75.

54. Rossouw GJ, Knott-Craig CJ, Barnard PM et al. Intracardiac operation in seven pregnant women. Ann Thorac Surg 1993; 55:1172–4.

55. Weiss BM, von Segesser LK, Alon E et al. Outcome of cardiovascular surgery and pregnancy: a systematic review of the period 1984–1996. Am J Obstet Gynecol 1998;179:1643–53.

56. Levy DL, Warriner RA, Burgess GE. Fetal response to cardiopulmonary bypass. Obstet Gynecol 1980;56:112–5.

57. Lamb MP, Ross K, Johnstone AM et al. Fetal heart monitoring during open heart surgery. Two case reports. Br J Obstet Gynecol 1981; 88:669-74.

58. El Maraghy M, Abou Senna I, El-Tehewy F et al. Mitral valvotomy in pregnancy. Am J Obstet Gynecol 1983; 145:708–10.

59. Vosloo S, Reichart B. The feasability of closed mitral valvotomy in pregnancy. J Thorac Cardiovasc Surg 1987; 93:675–9.

60. Pavankumar P, Venugopal P, Kaul U et al. Closed mitral valvotomy during pregnancy. A 20-year experience. Scand J Thor Cardiovasc Surg 1988;22:11–5.

61. Esteves CA, Ramos AIO, Braga SLN et al. Effectiveness of percutaneous balloon mitral valvotomy during pregnancy. Am J Cardiol 1991;68:930–4.

62. Patel JJ, Mitha AS, Hassen F et al. Percutaneous balloon mitral valvotomy in pregnant patients with tight pliable mitral stenosis. Am Heart J 1993;125:1106–9.

63. Iung B, Cormier B, Elias J et al. Usefulness of percutaneous balloon commissurotomy for mitral stenosis during pregnancy. Am J Cardiol 1994;73:398–400.

64. Kalra GS, Arora R, Khan JA et al. Percutaneous mitral commissurotomy for severe mitral stenosis during pregnancy. Cathet Cardiovasc Diagn 1994;33:28–30.

65. Gupta A, Lokhandwala Y, Satoskar P et al. Balloon mitral valvotomy in pregnancy: maternal and fetal outcomes. JAm Coll Surg 1998;187:409–15.

66. Ben Farhat M, Gamra H, Betbout F et al. Percutaneous balloon mitral commissurotomy during pregnancy. Heart 1997;77:564–7.

67. Mangione JA, Lourenco RM, dos Santos ES et al. Long-term followup of pregnant women after percutaneous mitral valvuloplasty. Catheter Cardiovasc Interv 2000;50:413–7.

68. De Souza JAM, Martinez EE, Ambrose JA et al. Percutaneous balloon mitral valvuloplasty in comparison with open mitral valve commissurotomy during pregnancy. J Am Coll Cardiol 2001;37: 900–3.

69. Patel JJ, Munclinger MJ, Mitha AS et al. Percutaneous bal-loon dilatation of the mitral valve in critically ill young patients with intractable heart failure. Br Heart J 1995; 73:555–8.

70. Lao TT, Sermer M, MaGee L et al. Congenital aortic stenosis and pregnancy—a reappraisal. Am J Obstet Gynecol 1993;169:540–5.

71. McIvor RA. Percutaneous balloon aortic valvuloplasty during pregnancy. Int J Cardiol 1991;32:1–3.

72. Lao TT, Adelman AG, Sermer M et al. Balloon valvuloplasty for congenital aortic stenosis in pregnancy. Br J Obstet Gynaecol 1993;100:1141–2.

73. Banning AP, Pearson JF, Hall RJ. Role of balloon dilatation of the aortic valve in pregnant patients with severe aortic stenosis. Br Heart J 1993;70:544–5.

74. Ben-Ami M, Battino S, Rosenfeld T et al. Aortic valve replacement during pregnancy. A case report and review of the literature. Acta Obstet Gynecol Scand 1990;69:651–3.

75. De Boer K, Ten Cate JW, Sturk A et al. Enhanced thrombin generation in normal and hypertensive pregnancy. Am J Obstet Gynecol 1989;160:95–100.

76. Chan WS, Anand S, Ginsberg JS. Anticoagulation of pregnant women with mechanical heart valves: a systematic review of the literature. Arch Intern Med 2000;160:191–6.

77. Sbarouni E, Oakley CM. Outcome of pregnancy in women with valve prostheses. Br Heart J 1994;71:196–201.

78. Sareli P, England MJ, Berk MR et al. Maternal and fetal sequelae of anticoagulation during pregnancy in patients with mechanical heart valve prostheses. Am J Cardiol 1989;63:1462–5.

79. Gohlke-Barwolf C, Acar J, Oakley C et al. Guidelines for prevention of thromboembolic events in valvular heart disease: Study Group of the Working Group on valvular heart disease of the European Society of Cardiology. Eur Heart J 1995;16:1320–30.

80. Prendergast B, Banning AP, Hall RJC. Valvular heart disease: recommendations for investigation and management. Summary of guidelines produced by a working group of the British Cardiac Society and the Research Unit of the Royal College of Physicians. J R Coll Physicians Lond 1996;30:309–15.

81. Bonow RO, Carabello B, De Leon AC et al. ACC/AHA guidelines for the management of patients with valvular heart disease. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. J Am Coll Cardiol 1998;32: 1486–588.

82. Oakley CM. Pregnancy and prosthetic heart valves. Lancet 1994;344:1643–4.

83. Elkayam UR. Anticoagulation in pregnant women with prosthetic heart valves: a double jeopardy. J Am Coll Cardiol 1996;27:1704–6.

84. Hanania G. Management of anticoagulants during pregnancy. Heart 2001;86:125–6.

85. Vitale N, De Feo M, De Santo LS et al. Dose-dependent fetal complications of warfarin in pregnant women with mechanical heart valves. J Am Coll Cardiol 1999;33:1637–41.

86. Salazar E, Izaguirre R, Verdejo J et al. Failure of adjusted doses of subcutaneous heparin to prevent thromboembolic phenomena in pregnant patients with mechanical cardiac valve prostheses. J Am Coll Cardiol 1996;27:1698–703.

87. Hanania G, Thomas D, Michel PL et al. Pregnancy and prosthetic heart valves: a French cooperative retrospective study of 155 cases. Eur Heart J 1994;15:1651–8.

88. Menschengieser SS, Fondevila CG, Santarelli MT et al. Anticoagulation in pregnant women with mechanical heart valve prostheses. Heart 1999;82:23–6.

89. Sadler L, McCowan L, White H et al. Pregnancy outcomes and cardiac complications in women with mechanical, bioprosthetic and homograft valves. Br J Obstet Gynaecol 2000;107:245–53.

90. Montalescot G, Polle V, Collet JP et al. Low molecular weight heparin after mechanical heart valve replacement.Circulation 2000;101: 1083–6.

91. Sanson BJ, Lensing AWA, Prins MH et al. Safety of lowmolecularweight heparin in pregnancy: a systematic review. Thromb Haemost 1999;81:668–72.

92. Lee LH. Low molecular weight heparin for thromboprophylaxis during pregnancy in 2 patients with mechanical mitral valve replacement. Thromb Haemost 1996;76:628–9.

93. Tenconi PM, Gatti L, Acaia B. Low molecular weight heparin in a pregnant woman with mechanical heart valve prosthesis: a case report. Thromb Haemost 1997;79:733.

94. Ginsberg JS, Greer I, Hirsh J. Use of antithrombotic agents during pregnancy. Chest 2001;119:122S–31S.

95. North RA, Sadler L, Stewart AW et al. Long-term survival and valverelated complications in young women with cardiac valve replacements. Circulation 1999;99:2669–76.

96. Piehler JM, Blackstone EH, Bailey KR et al. Reoperation on prosthetic heart values. Patient-specific estimates of inhospital events. J Thorac Cardiovasc Surg 1995;109:30–48.

97. Kee WD, Shen J, Chiu AT et al. Combined spinal-epidural analgesia in the management of labouring parturients with mitral stenosis. Anaesth Intensive Care 1999;27:523–6.

98. Brian JE Jr., Seifen AB, Clark RB. Aortic stenosis, cesarean delivery, and epidural anesthesia. J Clin Anesth 1993;5:154–7.

99. McKenna R, Cole ER, Vasan V. Is warfarin sodium contraindicated in the lactating mother? J Pediatr 1983;103:325–7. 101. Bac DJ, Lotgering FK, Verkaaaik APK et al. Spontaneous coronary artery dissection during pregnancy and postpartum. Eur Heart J 1995;16:136–8.

100. Rallings P, Exner T, Abraham R. Coronary artery vasculitis and myocardial infarction associated with antiphospholipid antibodies in a pregnant woman. Aust NZ J Med 1989;19:347–50.

101. Parry G, Goudevenos J-C, Williams DO. Coronary thrombosis postpartum in a young woman with Still's disease. Clin Cardiol 1992;15:305–7.

102. Pearson GD, Veille J-C. Peripartum cardiomyopathy: National Heart, Lung and Blood Institute and Office of Rare Diseases (National Institutes of Health) workshop recommendations and review. JAMA 2000;283:1183–8.

103. Van Hoeven KH, Kitsis RN, Katz SD et al. Peripartum versus idiopathic dilated cardiomyopathy in young women-a comparison of clinical, pathological and prognostic features. Int J Cardiol 1993;40:57–65.

104. Elkayam U, Tummala PP, Rao K et al. Maternal and fetal outcome of subsequent pregnancies in women with peripartum cardiomyopathy. New Engl J Med 2001;344:1567–71.

105. De Souza JL Jr., de Carvalho Frimm C, Nastari L et al. Left ventricular function after a new pregnancy in patients with peripartum cardiomyopathy. J Card Fail 2001;7:36–7.

106. Bozkurt B, Villaneuva FS, Holubkov R et al. Intravenous Immune globulin in the therapy of peripartum cardiomyopathy. J Am Coll Cardiol 1999;34:177–80.

107. Purcell IF, Williams DO. Peripartum cardiomyopathy complicating severe aortic stenosis. Int J Cardiol 1995;52:163–6.

108. Oakley CM, Nihoyannopoulos P. Peripartum cardiomyopathy with recovery in a patient with coincidental Eisenmenger ventricular septal defect. Br Heart J 1992;67:190–2.

109. Oakley CM. Hypertrophic cardiomyopathy in heart disease in pregnancy. New York: BMJ Publishing, 1997, p. 201–209.

110. Kazimuddin M, Vashist A, Basher AW et al. Pregnancy induced severe left ventricular systolic dysfunction in a patient with hypertrophic cardiomyopathy. Clin Cardiol 1998;21:848–50.

111. Redhead, Fadell EJ. Bacteraemia during parturition. JAMA 1959;160:1284–5.

112. Baker TH, Hubbell R. Reappraisal of asymptomatic puerperal bacteraemia. Am J Obstet Gynecol 1967;97:575–6.

113. Sugrue D, Blake S, Troy P. Antibiotic prophylaxis against infective endocarditis after normal delivery - is it necessary? Br Heart J 1980;44:499–522.

114. Joglar JA, Page RI. Treatment of cardiac arrhythmias during pregnancy; safety considerations. Drug Saf 1999;20:85–94.

115. Natale A, Davidson T, Geiger MJ. Implantable cardioverter defibrillators and pregnancy. A safe combination? Circulation 1997;96: 2808–12.

116. Report of the National High Blood Pressure Education Program Working Group on high blood pressure in pregnancy. Am J Obstet Gynecol 2000;183:S1–S22.

117. Higgins JR, de Swiet M. Blood pressure measurement and classification in pregnancy. Lancet 2001;357:131–5.

118. Walker JJ. Pre-eclampsia. Lancet 2000;356:1260–5.

119. Barton JR, O’Brien JM, Bergauer NK et al. Mild gestational hypertension remote from term: progression and outcome. Am J Obstet Gynecol 2001;184:979–83.

120. Sibai BM, Mabie WC, Shamsa F et al. A comparison of no medication versus methyl dopa or labetalol in chronic hypertension during pregnancy. Am J Obstet Gynecol 1990;162:960–5.

121. Sibai BM. Treatment of hypertension in pregnant women. N Engl J Med 1996;335:257–65.

122. Magee LA, Ornstein MP, von Dadelszen P. Fortnightly review: management of hypertension in pregnancy. BMJ 1999;318:1332–6.

123. Roberts JM, Cooper DW. Pathogenesis and genetics of preeclampsia. Lancet 2001;357:53–6.

124. Cockburn J, Moar VA, Ounsted M et al. Final report of study on hypertension during pregnancy: the effects of specific treatment on the growth and development of the children. Lancet 1982;1:647–9.

125. Nifedipine versus expectant management in mild to moderate hypertension in pregnancy. Gruppo di Studio ipertensione in Gravidanza. Br J Obstet Gynaecol 1998;105:718–22.

126. Magee LA, Schick B, Donnenfeld AE et al. The safety of calcium channel blockers in human pregnancy: a prospective multicenter cohort study. Am J Obstet Gynecol 1996;174:823–8.

127. Horvath JS, Phippard A, Korda A et al. Clonidine hydrochloride—a safe and effective antihypertensive agent in pregnancy. Obstet Gynecol 1985;66:634–8.

128. Lain Y, Roberts JM. Contemporary concepts of the pathogenesis and management of pre-eclampsia. JAMA 2002;287:3183–6.

129. Hanssens M, Keirse MJ, Vankelecom F et al. Fetal and neonatal effects of treatment with angiotensin-converting enzyme inhibitors in pregnancy. Obstet Gynecol 1991;78:128–35.

130. Heyborne KD. Pre-eclampsia prevention: lessons from the low dose aspirin therapy trials. Am J Obstet Gynecol 2000;183:523–8.

131. Duley L, Henderson-Smart DE, Knight M et al. Anti-platelet drugs for prevention of pre-eclampsia and its consequences: a systematic review. BMJ 2001;322:329–33.

132. Chambers JC, Fusi L, Malik IS et al. Association of maternal endothelial dysfunction with pre-eclampsia. JAMA 2001;285: 1607–12.